These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 31678379
1. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin. Chow MYT, Qiu Y, Liao Q, Kwok PCL, Chow SF, Chan HK, Lam JKW. Int J Pharm; 2019 Dec 15; 572():118818. PubMed ID: 31678379 [Abstract] [Full Text] [Related]
9. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity. Okuda T, Morishita M, Mizutani K, Shibayama A, Okazaki M, Okamoto H. J Control Release; 2018 Jun 10; 279():99-113. PubMed ID: 29627404 [Abstract] [Full Text] [Related]
15. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations. Hassan A, Farkas D, Longest W, Hindle M. Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220 [Abstract] [Full Text] [Related]
16. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X, Vogt FG, Hayes D, Mansour HM. J Pharm Sci; 2014 Sep 15; 103(9):2937-2949. PubMed ID: 24740732 [Abstract] [Full Text] [Related]
17. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria. Wang J, Kutter JP, Mu H, Moodley A, Yang M. Int J Pharm; 2020 Nov 30; 590():119877. PubMed ID: 32927003 [Abstract] [Full Text] [Related]
18. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D. Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834 [Abstract] [Full Text] [Related]
19. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus. Liang W, Chow MY, Lau PN, Zhou QT, Kwok PC, Leung GP, Mason AJ, Chan HK, Poon LL, Lam JK. Mol Pharm; 2015 Mar 02; 12(3):910-21. PubMed ID: 25599953 [Abstract] [Full Text] [Related]
20. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT. Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544 [Abstract] [Full Text] [Related] Page: [Next] [New Search]